Parkinson's disease decisions — 2025

The Board denied the Veteran's claim for revision of a May 2019 rating decision that assigned an initial 10 percent rating for Parkinson's disease, finding no clear and unmistakable error.

The Board denied service connection for Parkinson's disease as the evidence did not support a finding that it began during or is otherwise related to active service.

The Board remands the case to obtain an addendum opinion regarding whether the Veteran's service-connected Parkinson's disease and TERA (Camp Lejeune water contamination) contributed substantially or materially to his death.

The Board denied service connection for Parkinson's disease, emphysema, muscle cramps, bilateral shoulder disability, and neck disability. However, it granted service connection for peripheral vascular disease and asthma.

The Veteran is granted special monthly compensation (SMC) at the (r)(2) level due to his service-connected disabilities requiring a higher level of care.

The Board denied increased ratings for Parkinsonism and CAD, but granted SMC based on the loss of use of the hands and need for regular aid and attendance.

The Board denied service connection for diabetes mellitus and Parkinson's disease as there was no evidence of in-service incurrence or a nexus to service, including herbicide exposure.

The Board remands the claims for service connection for Parkinson's disease, hypertension, vertigo as secondary to Parkinson's disease, and acquired psychiatric disorder (also claimed as dementia and/or depression) as secondary to Parkinson's disease for further development.

The Board denied increased ratings for various conditions, including loss of the sense of smell, urinary problems, erectile dysfunction, and Parkinson's disease, among others.

The Veteran's combined disability rating for Parkinson's disease and its manifestations is 100 percent, and special monthly compensation at the rate set forth in 38 U.S.C. § 1114(r)(1) is granted.

The Board denied service connection for cognitive decline, to include as secondary to hypertension and remanded the claim for service connection for Parkinsonism, to include hand tremors.

The Board remands the case to obtain an adequate opinion regarding the Veteran's cause of death, specifically addressing toxic exposures during service and submitted medical literature.

The Board granted an effective date of November 20, 2018, for the awards of increased ratings to 50 percent for left upper extremity involvement and 40 percent for right upper extremity involvement associated with Parkinson's disease.

The Board granted an effective date of February 8, 2022, for the grant of service connection for Parkinson's Disease based on continuous pursuit and evidence of symptoms prior to formal diagnosis.

The Board remands the case to ensure all necessary efforts are made to verify the Veteran's claimed exposure to herbicides aboard the USS Oriskany.